Prevention of diabetic nephropathy

Area of Science:

• Nephrology
• Cardiology
• Pharmacology

Background:

• Chronic kidney disease (CKD) affects millions globally.
• Abnormal albumin or creatinine levels indicate kidney damage.
• Progression to end-stage renal disease (ESRD) necessitates dialysis or transplantation.

Purpose of the Study:

• To investigate the impact of blood pressure normalization on CKD progression.
• To evaluate the efficacy of ACE inhibitors or AT1-receptor blockers in patients with renal biomarkers.
• To determine the potential of these interventions in preventing or slowing ESRD.

Main Methods:

• Observational study analyzing patient data.
• Inclusion criteria: patients with abnormal albumin/creatinine levels.
• Intervention groups: blood pressure normalization, ACE inhibitor use, AT1-receptor blocker use.

Main Results:

• Blood pressure normalization significantly slowed CKD progression.
• ACE inhibitors and AT1-receptor blockers were effective in patients with abnormal renal biomarkers.
• These interventions demonstrated a potential to delay ESRD.

Conclusions:

• Blood pressure control is crucial for managing CKD.
• ACE inhibitors and AT1-receptor blockers are valuable therapeutic options for at-risk CKD patients.
• Early intervention can prevent or slow the advancement of kidney disease.